Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hollie Devine

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Seminars in Oncology Nursing|July 2, 2003
Hematopoietic cell transplantation in the treatment of leukemiaHollie Devine, Elaine DeMeyer
Seminars in Oncology Nursing|July 18, 2017
Young Adults with Multiple MyelomaHollie Devine, Daniel Verina
American Journal of Hematology|June 7, 2006
Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabineAmanda F Cashen, Hollie Devine, John DiPersio
Clinical Journal of Oncology Nursing|March 31, 2010
Mobilization of hematopoietic stem cells for use in autologous transplantationHollie Devine, D Kathryn Tierney, Kim Schmit-Pokorny, et al.
Clinical Journal of Oncology Nursing|September 26, 2017
Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients With Multiple Myeloma 
Donna Catamero, Kimberly Noonan, Tiffany Richards, et al.
Blood|April 23, 2008
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interactionSteven M Devine, Ravi Vij, Michael Rettig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemiaWilliam Blum, Rebecca B Klisovic, Bjoern Hackanson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabineWilliam Blum, Ramiro Garzon, Rebecca B Klisovic, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Seminars in Oncology Nursing|July 2, 2003
Hematopoietic cell transplantation in the treatment of leukemiaHollie Devine, Elaine DeMeyer
Seminars in Oncology Nursing|July 18, 2017
Young Adults with Multiple MyelomaHollie Devine, Daniel Verina
American Journal of Hematology|June 7, 2006
Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabineAmanda F Cashen, Hollie Devine, John DiPersio
Clinical Journal of Oncology Nursing|March 31, 2010
Mobilization of hematopoietic stem cells for use in autologous transplantationHollie Devine, D Kathryn Tierney, Kim Schmit-Pokorny, et al.
Clinical Journal of Oncology Nursing|September 26, 2017
Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients With Multiple Myeloma 
Donna Catamero, Kimberly Noonan, Tiffany Richards, et al.
Blood|April 23, 2008
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interactionSteven M Devine, Ravi Vij, Michael Rettig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemiaWilliam Blum, Rebecca B Klisovic, Bjoern Hackanson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabineWilliam Blum, Ramiro Garzon, Rebecca B Klisovic, et al.
Pageof 1